Search research articles
Contact Us
Filters
Showing results (51-60 of 531) with videos related to
Page
of 54
Sort By:
The Journal of Antimicrobial Chemotherapy
|
July 22, 2004
Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study
Steven D Brown, Michael J Rybak
Antimicrobial Agents and Chemotherapy
|
March 1, 1996
Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa
D M Cappelletty, M J Rybak
Antimicrobial Agents and Chemotherapy
|
June 20, 2000
In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model
R L Akins, M J Rybak
Antimicrobial Agents and Chemotherapy
|
July 1, 1995
Pharmacodynamics of RP 59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot model
S L Kang, M J Rybak
Antimicrobial Agents and Chemotherapy
|
March 1, 1993
Teicoplanin and daptomycin bactericidal activities in the presence of albumin or serum under controlled conditions of pH and ionized calcium
K C Lamp, M J Rybak
The Journal of Antimicrobial Chemotherapy
|
May 1, 1997
In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus
S L Kang, M J Rybak
Pharmacotherapy
|
April 9, 2020
COVID-19: Important Therapy Considerations and Approaches in this Hour of Need
Thomas P Lodise, Michael J Rybak
Antimicrobial Agents and Chemotherapy
|
November 25, 2004
Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model
Kerry L LaPlante, Michael J Rybak
Pharmacotherapy
|
September 1, 1995
Vancomycin-resistant enterococci
M J Rybak, S M Palmer
Pharmacotherapy
|
September 1, 1996
Vancomycin-resistant enterococci
S M Palmer, M J Rybak
Page
of 54
Search research articles
Search
Showing results (51-60 of 531) with videos related to
Sort By:
Page
of 54
The Journal of Antimicrobial Chemotherapy
|
July 22, 2004
Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study
Steven D Brown, Michael J Rybak
Antimicrobial Agents and Chemotherapy
|
March 1, 1996
Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa
D M Cappelletty, M J Rybak
Antimicrobial Agents and Chemotherapy
|
June 20, 2000
In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model
R L Akins, M J Rybak
Antimicrobial Agents and Chemotherapy
|
July 1, 1995
Pharmacodynamics of RP 59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot model
S L Kang, M J Rybak
Antimicrobial Agents and Chemotherapy
|
March 1, 1993
Teicoplanin and daptomycin bactericidal activities in the presence of albumin or serum under controlled conditions of pH and ionized calcium
K C Lamp, M J Rybak
The Journal of Antimicrobial Chemotherapy
|
May 1, 1997
In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus
S L Kang, M J Rybak
Pharmacotherapy
|
April 9, 2020
COVID-19: Important Therapy Considerations and Approaches in this Hour of Need
Thomas P Lodise, Michael J Rybak
Antimicrobial Agents and Chemotherapy
|
November 25, 2004
Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model
Kerry L LaPlante, Michael J Rybak
Pharmacotherapy
|
September 1, 1995
Vancomycin-resistant enterococci
M J Rybak, S M Palmer
Pharmacotherapy
|
September 1, 1996
Vancomycin-resistant enterococci
S M Palmer, M J Rybak
Page
of 54